查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2012621

草藥市場：依類型、劑型、傳統醫學系統、植物來源、適應症及通路分類－2026年至2032年全球市場預測

Herbal Medicine Market by Type, Formulation, Traditional System, Botanical Origin, Indication, Distribution Channel - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 181 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，草藥市值將達到 713.9 億美元，到 2026 年將成長至 780.7 億美元，到 2032 年將達到 1351.3 億美元，複合年成長率為 9.54%。

主要市場統計數據
基準年 2025 713.9億美元
預計年份：2026年 780.7億美元
預測年份 2032 1351.3億美元
複合年成長率 (%) 9.54%

對現代草藥生態系統進行權威概述，涵蓋不斷變化的消費者需求、科學檢驗趨勢以及相關人員的期望。

現代草藥產業正處於傳承數百年的傳統與當代快速創新交匯的十字路口。隨著植物化學、臨床檢驗和品質保證實踐的進步，消費者對自然療法、預防保健和輔助保健的興趣也日益成熟。因此，研發、生產、分銷和臨床實踐等各環節的相關人員正在重塑植物來源產品的開發、定位和監管方式。

結構創新、監管加強和數位化加速的整合，從根本上重塑了產品開發、採購和商業化的動態。

過去五年，我們見證了草藥產業發生的翻天覆地的變化，從生產到病患治療效果，都發生了根本性的改變。分析化學和基因組學的進步提高了物種鑑定和污染物檢測的準確性，使生產者能夠提供更穩定、更可預測的產品。同時，數位健康平台和遠端醫療的發展降低了資訊取得和傳播的門檻，加速了直接面對消費者的銷售管道，同時也提高了人們對臨床證據和安全性數據的期望。

對 2025 年美國關稅措施如何刺激整個價值鏈中來源多元化、業務永續營運和監管合規性的投資進行實證分析。

美國2025年實施的新關稅對整個中藥產業的植物性原料供應鏈、籌資策略和市場定位產生了多方面的影響。對某些植物性原料和成品製​​劑徵收的進口關稅促使企業重新評估供應商組合，鼓勵採購團隊實現採購區域多元化，降低單一產地風險，並與供應商建立更緊密、更直接的合作關係。隨著企業不斷調整，許多企業優先選擇擁有完善的可追溯系統和垂直整合能力的供應商，以降低關稅相關的波動風險。

將產品形式、植物原料來源、產品類型、治療適應症和通路趨勢與策略組合決策連結起來的綜合細分洞察。

市場區隔為產品策略、研發重點和通路投資的優先排序提供了策略觀點。基於劑型，相關人員會重新思考消費者更傾向於以何種方式獲得草藥的功效。乳膏和軟膏、精油、液體萃取物、粉劑、糖漿、片劑和膠囊以及茶和花草茶等劑型，各自在配方、穩定性和合規性方面都有其獨特的考量，這些都會影響生產和保存期限策略。除了劑型的選擇，植物的來源也是決定性因素。樹皮、花朵、果實和種子、葉子和根的活性成分組成、收穫週期和永續性各不相同。因此，植物的選擇不僅決定了治療目的，也決定了供應風險和可追溯性要求。

區域比較分析突顯了美洲、歐洲、中東和非洲以及亞太地區草藥產品供應鏈的優勢、監管差異及其影響。

區域趨勢對整個草藥生態系統的供應鏈、監管方式和消費者偏好都產生了深遠的影響。在美洲，完善的零售基礎設施和消費者對循證天然保健方案日益成長的興趣，為優質化配方和臨床導向型膳食補充劑創造了有利條件。同時，國內種植和加工致力於減少對進口的依賴，並提高原產地資訊的透明度。跨境貿易協定和關稅體系進一步影響籌資策略，因為企業需要在取得特定植物品種和成本之間取得平衡。

對競爭趨勢進行了深入的評估，展示了原料專家、契約製造製造商、數位原生品牌和醫療保健專業網路如何塑造行業整合和差異化。

競爭格局由眾多能力互補的參與者組成，涵蓋原料專家、契約製造、數位原生品牌以及醫療保健專業人士主導公司。提供檢驗萃取物和品管服務的原料供應商是品牌的策略合作夥伴，能夠幫助他們加快產品開發進程，同時確保活性成分的一致性。契約製造製造商和自有品牌合作夥伴則能為新興品牌帶來規模經濟效益，使其能夠將資源集中於行銷、效能驗證和分銷。

經營團隊可採取的策略重點，以加強供應商生態系統、加快證據計畫、最佳化管道並提高製造敏捷性。

行業領導者應採取一系列明確的行動，在商業性靈活性和長期韌性之間取得平衡。首先，應建構一個重視多樣性、可追溯性和品質保證共同投資的供應商生態系統，而不是依賴單一的採購模式。加強與採購地區的本地夥伴關係，並投資於供應商能力建設，將有助於降低關稅和氣候變遷相關衝擊帶來的風險，同時增強永續發展能力。

為了確保獲得可靠且可操作的見解，我們採用了嚴謹的混合方法研究框架，結合了初步訪談、文件分析、供應鏈追蹤和專家檢驗。

本研究途徑融合了多種研究手段，旨在確保研究結果的有效性、可靠性和實際應用性。主要研究工作包括與各類相關人員進行結構化訪談和深入討論，這些利害關係人包括產品開發人員、供應鏈經理、法規遵循專家、臨床醫生和通路合作夥伴。除這些對話外，還開展了實地考察和虛擬設施審核，以評估種植實踐、加工能力和品管程序。

這份簡明扼要的報告總結了風險、韌性和機遇，顯示科學檢驗、可追溯性和負責任的商業化將如何決定未來的贏家。

不斷發展的草藥產業既蘊含著機遇，也面臨挑戰。調查方法和臨床方法的進步，加上數位化分銷和日益嚴格的監管要求，正在提升整個價值鏈的標準。那些投資於透明供應鏈、健全品質系統和可靠證據的企業，將更有能力掌握不斷變化的消費者偏好和日益嚴格的監管環境所帶來的機會。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章：草藥市場：按類型分類

  • 草本營養補充品
  • 草本機能性食品
  • 草藥

第9章 中藥材市場：依劑型分類

  • 乳膏和軟膏
    • 消炎乳膏
    • 草本止痛膏
  • 液體萃取物
    • 酒精酊劑
    • 甘油萃取物
    • 水溶性萃取物
  • 油
    • 精油
    • 按摩油
  • 粉末
    • 草藥混合粉
    • 單味藥粉
  • 糖漿
    • 蜂蜜糖漿
    • 糖漿
  • 片劑和膠囊
    • 咀嚼片
    • 壓縮鎖
    • 發泡

第10章：草藥市場：依傳統醫學體系分類

  • 阿育吠陀
  • 藏醫與蒙醫
  • 中藥
  • 日本傳統醫學
  • 韓國傳統醫學

第11章：草藥市場：植物來源來源分類

  • 吠
  • 花
  • 水果和種子
  • 葉子
  • 根

第12章 草藥市場：依適應症分類

  • 心血管健康
  • 糖尿病管理
  • 消化系統疾病
  • 精神疾病
  • 疼痛管理
  • 呼吸系統疾病
  • 皮膚病

第13章 草藥市場：依通路分類

  • 離線
    • 直銷
    • 藥局
    • 超級市場/大賣場
  • 線上
    • 企業網站
    • 電子商務網站

第14章 草藥市場：依地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第15章 草藥市場：依類別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第16章 草藥市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第17章：美國：草藥市場

第18章 中國：草藥市場

第19章 競爭情勢

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Amway Corp.
  • Ayush Herbs herbal products Company
  • Baidyanath Ayurved
  • Bayer AG
  • Bionorica SE
  • Blackmores Limited
  • China Traditional Chinese Medicine Holdings Co. Ltd.
  • Cultivator Natural Products Pvt. Ltd.
  • DABUR Limited
  • Emami Limited
  • Gaia Herbs, Inc.
  • HENAN ENZ PHARMTECH CO., LTD.
  • Herbal Hills
  • HERBALIFE LTD.
  • Himalaya Global Holdings Ltd.
  • LKK Health Products Group Limited
  • Nature's Answer, LLC
  • Nature's Way Brands, LLC
  • Nordic Naturals
  • NOW Health Group, Inc.
  • Nutraceutical Corporation
  • Organic India Pvt. Ltd.
  • Patanjali Ayurved Limited
  • Schwabe Group
  • Sheng Chang Pharmaceutical Company
  • Shreenaina Naturals
  • Teikoku Seiyaku Co.,Ltd.
  • Tsumura & Co.
  • Weleda（UK）Limited
  • ZeinPharma Germany GmbH
Product Code: MRR-4331C112E07A

The Herbal Medicine Market was valued at USD 71.39 billion in 2025 and is projected to grow to USD 78.07 billion in 2026, with a CAGR of 9.54%, reaching USD 135.13 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 71.39 billion
Estimated Year [2026] USD 78.07 billion
Forecast Year [2032] USD 135.13 billion
CAGR (%) 9.54%

An authoritative orientation to the modern herbal medicine ecosystem, capturing consumer demand shifts, scientific validation trends, and stakeholder expectations

The contemporary herbal medicine landscape sits at the intersection of centuries-old traditions and rapid modern innovation. Consumer interest in natural, preventive, and complementary healthcare options has matured alongside advances in phytochemistry, clinical validation, and quality assurance practices. As a result, stakeholders across research, manufacturing, distribution, and clinical practice are recalibrating how botanical products are developed, positioned, and regulated.

This introduction frames the critical dynamics shaping product portfolios, sourcing decisions, and commercial models. It highlights the roles of evidence generation, safety and traceability systems, and retail innovations such as digital pharmacies and subscription models that are redefining accessibility. Importantly, the rise of hybrid offerings that blend conventional pharmacology with botanical synergies is changing how clinicians and consumers evaluate efficacy and risk.

Through a lens of stakeholder alignment, the section contextualizes how regulators, payers, and practitioners are increasingly focused on standardized quality, reproducible dosing, and transparent supply chains. It also outlines the evolving expectations of discerning consumers who demand sustainability credentials and verifiable efficacy data. Taken together, these forces create both opportunity and complexity for organizations seeking to scale responsibly in this rapidly evolving sector.

A synthesis of structural innovations, regulatory tightening, and digital acceleration that are fundamentally reshaping product development, sourcing, and commercialization dynamics

The past five years have seen transformative shifts that are remapping the herbal medicine landscape from production to patient outcomes. Advances in analytical chemistry and genomics have improved species identification and adulteration detection, enabling manufacturers to deliver more consistent and predictable products. Simultaneously, the growth of digital health platforms and telemedicine has lowered barriers to information and distribution, accelerating direct-to-consumer channels while elevating expectations for clinical evidence and safety data.

Regulatory ecosystems are adapting in parallel, with authorities emphasizing good manufacturing practices, provenance documentation, and adverse-event reporting. This regulatory tightening-coupled with consumer demand for sustainability-has driven investments in traceable supply chains, responsible harvesting, and supplier partnerships that prioritize long-term resource stewardship. Innovation in dosing formats and delivery systems, ranging from microencapsulated extracts to transdermal gels, is reshaping product development priorities and opening new therapeutic niches.

At the same time, commercialization is increasingly collaborative: contract manufacturing and ingredient-specialist firms are partnering with brand owners to accelerate time-to-market while enabling smaller innovators to scale. These shifts reflect a broader industry maturation where scientific rigour, digital reach, and supply chain integrity jointly determine competitive differentiation and long-term viability.

A pragmatic analysis of how 2025 United States tariff measures have catalyzed sourcing diversification, operational resilience, and regulatory-compliance investments across the value chain

The introduction of new tariffs by the United States in 2025 has had a multifaceted effect on botanical supply chains, procurement strategies, and commercial positioning across the herbal medicine sector. Import duties on certain botanical inputs and finished formulations have prompted a re-evaluation of supplier portfolios, encouraging procurement teams to diversify sourcing geographies and to build closer direct-supplier relationships that reduce exposure to single-origin risk. As firms adapt, many are prioritizing suppliers with strong traceability systems and vertically integrated capabilities to mitigate tariff-driven volatility.

Tariff pressure has also influenced formulation and packaging choices, with product developers seeking to optimize input lists and packaging footprints to limit cross-border cost exposure. Manufacturers facing higher landed costs have responded through a combination of operational efficiency programs, changed logistics routing, and selective cost pass-through to trade partners. For some brands, this has meant compressing promotional cycles and re-prioritizing channel investments toward higher-margin direct channels where pricing elasticity can be better managed.

Beyond immediate commercial adjustments, tariffs have accelerated strategic conversations about onshoring critical production steps, investing in regional manufacturing capacity, and deepening supplier development programs in lower-tariff jurisdictions. These adaptations are prompting a shift from transactional sourcing toward supplier ecosystem development, where long-term partnerships, technical collaboration, and shared investments in quality assurance become integral to resilience. At the same time, compliance teams are investing more in trade classification expertise and origin verification to ensure tariff treatments are properly applied, thereby reducing unexpected cost leakage and reputational risk.

Integrated segmentation insights that connect product form, botanical origin, product type, therapeutic indication, and channel dynamics to strategic portfolio decisions

Segmentation provides the strategic lens through which product strategies, R&D focus, and channel investments are prioritized. Based on form, stakeholders are rethinking how consumers prefer to receive herbal benefits, with Creams & Ointments, Essential Oils, Liquid Extracts, Powders, Syrups, Tablets & Capsules, and Teas & Infusions each presenting distinct formulation, stability, and compliance considerations that influence manufacturing and shelf-life strategies. Parallel to form choices, botanical origin is a decisive factor: Bark, Flowers, Fruits & Seeds, Leaves, and Roots vary in active constituent profiles, harvest cycles, and sustainability constraints; botanical selection therefore determines not only therapeutic intent but also supply risk and traceability requirements.

Type-based segmentation differentiates product positioning and commercialization routes. Herbal Beauty Products and Cosmetics demand high sensory quality and regulatory labeling that aligns with cosmetic standards, while Herbal Dietary Supplements and Herbal Functional Foods straddle nutrition and health positioning with an emphasis on consumer trust and scientific substantiation. Herbal Pharmaceutical Products require a higher threshold of clinical evidence and regulatory compliance, influencing development timelines and distribution partnerships. Indication-driven segmentation-spanning Cardiovascular Health, Digestive Disorders, General Wellness & Immunity Boosting, Liver & Kidney Disorders, Mental Health, Respiratory Conditions, Sexual Health & Reproductive Issues, and Skin Disorders-guides R&D prioritization and claims strategy, with some indications more amenable to evidence generation than others.

Distribution channels shape access and brand experience. Ayurvedic Clinics & Traditional Healers offer clinical credibility and culturally embedded trust; Direct Selling leverages personal networks and experiential marketing; Health & Wellness Stores and Hospital & Retail Pharmacies provide curated, clinical-facing touchpoints; Online Pharmacies / E-commerce enable scale and data-driven targeting; while Supermarkets / Hypermarkets deliver broad visibility and convenience. Understanding how these segments interact-how a particular form sourced from specific botanical origins aligns with regulatory expectations for a given indication and channel-enables portfolio optimization that is both commercially viable and compliant.

Comparative regional analysis highlighting the Americas, Europe Middle East & Africa, and Asia-Pacific strengths, regulatory variations, and supply chain implications for herbal products

Regional dynamics exert a powerful influence on supply chains, regulatory approaches, and consumer preferences across the herbal medicine ecosystem. In the Americas, established retail infrastructures and growing consumer interest in evidence-based natural health solutions create fertile conditions for premiumized formulations and clinically oriented supplements, while domestic cultivation and processing initiatives seek to reduce import dependency and improve provenance transparency. Cross-border trade agreements and tariff regimes further shape sourcing strategies, with companies balancing costs against access to specific botanical species.

Europe, Middle East & Africa presents a heterogeneous landscape where regulatory stringency, cultural acceptance of traditional medicine, and varying levels of manufacturing capacity demand nuanced market entry approaches. In parts of Europe, strong regulatory oversight and consumer protection frameworks necessitate rigorous quality systems and clear claims substantiation, whereas regions with entrenched traditional medicine practices provide alternative channels and partnership models with traditional healers and community practitioners.

The Asia-Pacific region remains a critical supplier and innovation hub, combining rich botanical biodiversity with deep traditional knowledge systems and significant manufacturing scale. Local consumer familiarity with herbal modalities supports rapid product adoption, while investments in standardized extraction technologies and GMP-compliant facilities are elevating export readiness. Across these regions, comparative strengths-ranging from raw material endowments to regulatory sophistication-inform strategic decisions about production location, R&D collaboration, and channel prioritization.

Insightful appraisal of competitive dynamics showing how ingredient specialists, contract manufacturers, digital-native brands, and practitioner networks are shaping consolidation and differentiation

The competitive landscape comprises diverse players with complementary capabilities, ranging from ingredient specialists and contract manufacturers to digitally native brands and practitioner-led enterprises. Ingredient suppliers that provide validated extracts and quality control services have become strategic partners for brands seeking to accelerate formulation timelines while ensuring consistent active profiles. Contract manufacturers and private-label partners enable scale for emerging brands, allowing them to focus resources on marketing, claims substantiation, and channel development.

Digital-first consumer brands are differentiating through direct engagement, data-driven personalization, and agile product launches, often using subscription models to enhance lifetime value. Traditional practitioners and clinic networks remain influential in segments where cultural trust and in-person diagnosis are important, creating hybrid commercialization models that blend clinical validation with community endorsement. Across the industry, there is growing evidence of strategic alliances and M&A activity aimed at consolidating supply chains, acquiring technical capabilities, and expanding geographic reach.

Quality assurance and regulatory compliance functions are increasingly central to competitive positioning. Firms investing in traceability, third-party testing, and transparent labeling are gaining credibility among both consumers and institutional buyers. At the same time, partnerships between science-led organizations and herbal experts are enabling more robust clinical programs that enhance product legitimacy and broaden acceptance within conventional healthcare pathways.

Action-oriented strategic priorities for executives to strengthen supplier ecosystems, accelerate evidence programs, optimize channels, and enhance manufacturing agility

Industry leaders should pursue a clear set of prioritized actions that balance commercial agility with long-term resilience. First, build supplier ecosystems that emphasize diversity, traceability, and co-investment in quality assurance rather than relying on single-source procurement models. Strengthening on-the-ground partnerships in sourcing regions and investing in supplier capacity development will reduce exposure to tariff and climate-related shocks while improving sustainability credentials.

Second, accelerate evidence-generation programs that align with target indications and distribution channels. For consumer-facing wellness products, pragmatic real-world evidence and validated biomarkers can support credible positioning, while for pharmaceutical-grade products, more rigorous clinical pathways should be pursued. Third, optimize channel mix by reallocating investment toward high-value touchpoints; direct channels and clinician-mediated distribution can offer better margin control and data capture, enabling more targeted product iterations.

Fourth, enhance operational flexibility through geographic manufacturing diversification and modular production capabilities that allow rapid reconfiguration in response to trade or regulatory shifts. Finally, embed regulatory and trade-classification expertise into commercial planning to anticipate cross-border cost exposure and to exploit preferential trade arrangements where available. Taken together, these steps create a cohesive approach to mitigate near-term shocks and to build durable competitive advantage.

A rigorous mixed-methods research framework combining primary interviews, documentary analysis, supply chain tracing, and expert validation to ensure credible and actionable findings

The research approach combines mixed-methods techniques designed to ensure validity, credibility, and practical applicability. Primary research included structured interviews and in-depth discussions with a diverse set of stakeholders such as product developers, supply-chain managers, regulatory affairs specialists, clinical practitioners, and channel partners. These conversations were complemented by site-level reviews and virtual facility audits to assess cultivation practices, processing capabilities, and quality-control procedures.

Secondary research synthesized regulatory documents, peer-reviewed literature, and technical standards to construct a detailed picture of compliance expectations and evolving best practices. Supply chain tracing used origin verification tools and certificate review to evaluate provenance and to identify concentration risks. Qualitative synthesis methods were applied to reconcile differing stakeholder perspectives and to surface actionable themes, while internal triangulation against documentary evidence ensured consistency and reduced bias.

Throughout the process, emphasis was placed on transparency: methodology appendices document interview protocols, selection criteria, and validation steps. Findings were iteratively reviewed with subject-matter experts to ensure technical accuracy and to validate implications for strategy and operations. This multi-layered approach supports conclusions that are both evidence-based and directly usable by commercial and technical decision-makers.

A concise synthesis of risk, resilience, and opportunity showing how scientific validation, traceability, and responsible commercialization will determine future winners

The evolving herbal medicine sector presents a blend of opportunity and responsibility. Advances in analytical and clinical methodologies, combined with digital distribution and heightened regulatory expectations, are elevating standards across the value chain. Organizations that invest in transparent supply chains, robust quality systems, and credible evidence generation will be best positioned to capitalize on shifting consumer preferences and tighter regulatory scrutiny.

Resilience will depend on strategic diversification of sourcing, selective onshoring or regional capacity development, and the ability to rapidly reconfigure operations in response to trade or environmental disruptions. Equally important is the cultivation of trust through transparent communication, third-party verification, and targeted clinical programs that substantiate claims while protecting consumer safety. For leaders, the imperative is to align commercial ambitions with sustainable procurement and scientific rigor, thereby ensuring long-term brand integrity and regulatory compliance.

In sum, the sector is moving from fragmentation toward professionalization, where scientific validation, supply chain integrity, and responsible commercialization jointly determine which products and companies will scale successfully in the coming years.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Herbal Medicine Market, by Type

  • 8.1. Herbal Dietary Supplements
  • 8.2. Herbal Functional Foods
  • 8.3. Herbal Pharmaceutical Products

9. Herbal Medicine Market, by Formulation

  • 9.1. Creams & Ointments
    • 9.1.1. Anti-Inflammatory Creams
    • 9.1.2. Herbal Analgesic Ointments
  • 9.2. Liquid Extracts
    • 9.2.1. Alcohol-Based Tinctures
    • 9.2.2. Glycerin-Based Extracts
    • 9.2.3. Water-Based Extracts
  • 9.3. Oils
    • 9.3.1. Essential Oils
    • 9.3.2. Massage Oils
  • 9.4. Powders
    • 9.4.1. Herbal Blend Powders
    • 9.4.2. Single Herb Powders
  • 9.5. Syrups
    • 9.5.1. Honey-Based Syrups
    • 9.5.2. Sugar-Based Syrups
  • 9.6. Tablets & Capsules
    • 9.6.1. Chewable Tablets
    • 9.6.2. Compressed Tablets
    • 9.6.3. Effervescent Tablets

10. Herbal Medicine Market, by Traditional System

  • 10.1. Ayurveda
  • 10.2. Tibetan & Mongolian Medicine
  • 10.3. Traditional Chinese Medicine
  • 10.4. Traditional Japanese Medicine
  • 10.5. Traditional Korean Medicine

11. Herbal Medicine Market, by Botanical Origin

  • 11.1. Bark
  • 11.2. Flowers
  • 11.3. Fruits & Seeds
  • 11.4. Leaves
  • 11.5. Roots

12. Herbal Medicine Market, by Indication

  • 12.1. Cardiovascular Health
  • 12.2. Diabetes Management
  • 12.3. Digestive Disorders
  • 12.4. Mental Health Disorders
  • 12.5. Pain Management
  • 12.6. Respiratory Disorders
  • 12.7. Skin Disorders

13. Herbal Medicine Market, by Distribution Channel

  • 13.1. Offline
    • 13.1.1. Direct Sales
    • 13.1.2. Pharmacies
    • 13.1.3. Supermarkets / Hypermarkets
  • 13.2. Online
    • 13.2.1. Company Website
    • 13.2.2. eCommerce Website

14. Herbal Medicine Market, by Region

  • 14.1. Americas
    • 14.1.1. North America
    • 14.1.2. Latin America
  • 14.2. Europe, Middle East & Africa
    • 14.2.1. Europe
    • 14.2.2. Middle East
    • 14.2.3. Africa
  • 14.3. Asia-Pacific

15. Herbal Medicine Market, by Group

  • 15.1. ASEAN
  • 15.2. GCC
  • 15.3. European Union
  • 15.4. BRICS
  • 15.5. G7
  • 15.6. NATO

16. Herbal Medicine Market, by Country

  • 16.1. United States
  • 16.2. Canada
  • 16.3. Mexico
  • 16.4. Brazil
  • 16.5. United Kingdom
  • 16.6. Germany
  • 16.7. France
  • 16.8. Russia
  • 16.9. Italy
  • 16.10. Spain
  • 16.11. China
  • 16.12. India
  • 16.13. Japan
  • 16.14. Australia
  • 16.15. South Korea

17. United States Herbal Medicine Market

18. China Herbal Medicine Market

19. Competitive Landscape

  • 19.1. Market Concentration Analysis, 2025
    • 19.1.1. Concentration Ratio (CR)
    • 19.1.2. Herfindahl Hirschman Index (HHI)
  • 19.2. Recent Developments & Impact Analysis, 2025
  • 19.3. Product Portfolio Analysis, 2025
  • 19.4. Benchmarking Analysis, 2025
  • 19.5. Amway Corp.
  • 19.6. Ayush Herbs herbal products Company
  • 19.7. Baidyanath Ayurved
  • 19.8. Bayer AG
  • 19.9. Bionorica SE
  • 19.10. Blackmores Limited
  • 19.11. China Traditional Chinese Medicine Holdings Co. Ltd.
  • 19.12. Cultivator Natural Products Pvt. Ltd.
  • 19.13. DABUR Limited
  • 19.14. Emami Limited
  • 19.15. Gaia Herbs, Inc.
  • 19.16. HENAN ENZ PHARMTECH CO., LTD.
  • 19.17. Herbal Hills
  • 19.18. HERBALIFE LTD.
  • 19.19. Himalaya Global Holdings Ltd.
  • 19.20. LKK Health Products Group Limited
  • 19.21. Nature's Answer, LLC
  • 19.22. Nature's Way Brands, LLC
  • 19.23. Nordic Naturals
  • 19.24. NOW Health Group, Inc.
  • 19.25. Nutraceutical Corporation
  • 19.26. Organic India Pvt. Ltd.
  • 19.27. Patanjali Ayurved Limited
  • 19.28. Schwabe Group
  • 19.29. Sheng Chang Pharmaceutical Company
  • 19.30. Shreenaina Naturals
  • 19.31. Teikoku Seiyaku Co.,Ltd.
  • 19.32. Tsumura & Co.
  • 19.33. Weleda (U.K) Limited
  • 19.34. ZeinPharma Germany GmbH

LIST OF FIGURES

  • FIGURE 1. GLOBAL HERBAL MEDICINE MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL HERBAL MEDICINE MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL HERBAL MEDICINE MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL HERBAL MEDICINE MARKET SIZE, BY TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL HERBAL MEDICINE MARKET SIZE, BY FORMULATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL HERBAL MEDICINE MARKET SIZE, BY TRADITIONAL SYSTEM, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL HERBAL MEDICINE MARKET SIZE, BY BOTANICAL ORIGIN, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL HERBAL MEDICINE MARKET SIZE, BY INDICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL HERBAL MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL HERBAL MEDICINE MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL HERBAL MEDICINE MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL HERBAL MEDICINE MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 13. UNITED STATES HERBAL MEDICINE MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 14. CHINA HERBAL MEDICINE MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL HERBAL MEDICINE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL HERBAL MEDICINE MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL HERBAL MEDICINE MARKET SIZE, BY HERBAL DIETARY SUPPLEMENTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL HERBAL MEDICINE MARKET SIZE, BY HERBAL DIETARY SUPPLEMENTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL HERBAL MEDICINE MARKET SIZE, BY HERBAL DIETARY SUPPLEMENTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL HERBAL MEDICINE MARKET SIZE, BY HERBAL FUNCTIONAL FOODS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL HERBAL MEDICINE MARKET SIZE, BY HERBAL FUNCTIONAL FOODS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL HERBAL MEDICINE MARKET SIZE, BY HERBAL FUNCTIONAL FOODS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL HERBAL MEDICINE MARKET SIZE, BY HERBAL PHARMACEUTICAL PRODUCTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL HERBAL MEDICINE MARKET SIZE, BY HERBAL PHARMACEUTICAL PRODUCTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL HERBAL MEDICINE MARKET SIZE, BY HERBAL PHARMACEUTICAL PRODUCTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL HERBAL MEDICINE MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL HERBAL MEDICINE MARKET SIZE, BY CREAMS & OINTMENTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL HERBAL MEDICINE MARKET SIZE, BY CREAMS & OINTMENTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL HERBAL MEDICINE MARKET SIZE, BY CREAMS & OINTMENTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL HERBAL MEDICINE MARKET SIZE, BY CREAMS & OINTMENTS, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL HERBAL MEDICINE MARKET SIZE, BY ANTI-INFLAMMATORY CREAMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL HERBAL MEDICINE MARKET SIZE, BY ANTI-INFLAMMATORY CREAMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL HERBAL MEDICINE MARKET SIZE, BY ANTI-INFLAMMATORY CREAMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL HERBAL MEDICINE MARKET SIZE, BY HERBAL ANALGESIC OINTMENTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL HERBAL MEDICINE MARKET SIZE, BY HERBAL ANALGESIC OINTMENTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL HERBAL MEDICINE MARKET SIZE, BY HERBAL ANALGESIC OINTMENTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL HERBAL MEDICINE MARKET SIZE, BY LIQUID EXTRACTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL HERBAL MEDICINE MARKET SIZE, BY LIQUID EXTRACTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL HERBAL MEDICINE MARKET SIZE, BY LIQUID EXTRACTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL HERBAL MEDICINE MARKET SIZE, BY LIQUID EXTRACTS, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL HERBAL MEDICINE MARKET SIZE, BY ALCOHOL-BASED TINCTURES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL HERBAL MEDICINE MARKET SIZE, BY ALCOHOL-BASED TINCTURES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL HERBAL MEDICINE MARKET SIZE, BY ALCOHOL-BASED TINCTURES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL HERBAL MEDICINE MARKET SIZE, BY GLYCERIN-BASED EXTRACTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL HERBAL MEDICINE MARKET SIZE, BY GLYCERIN-BASED EXTRACTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL HERBAL MEDICINE MARKET SIZE, BY GLYCERIN-BASED EXTRACTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL HERBAL MEDICINE MARKET SIZE, BY WATER-BASED EXTRACTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL HERBAL MEDICINE MARKET SIZE, BY WATER-BASED EXTRACTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL HERBAL MEDICINE MARKET SIZE, BY WATER-BASED EXTRACTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL HERBAL MEDICINE MARKET SIZE, BY OILS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL HERBAL MEDICINE MARKET SIZE, BY OILS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL HERBAL MEDICINE MARKET SIZE, BY OILS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL HERBAL MEDICINE MARKET SIZE, BY OILS, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL HERBAL MEDICINE MARKET SIZE, BY ESSENTIAL OILS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL HERBAL MEDICINE MARKET SIZE, BY ESSENTIAL OILS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL HERBAL MEDICINE MARKET SIZE, BY ESSENTIAL OILS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL HERBAL MEDICINE MARKET SIZE, BY MASSAGE OILS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL HERBAL MEDICINE MARKET SIZE, BY MASSAGE OILS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL HERBAL MEDICINE MARKET SIZE, BY MASSAGE OILS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL HERBAL MEDICINE MARKET SIZE, BY POWDERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL HERBAL MEDICINE MARKET SIZE, BY POWDERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL HERBAL MEDICINE MARKET SIZE, BY POWDERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL HERBAL MEDICINE MARKET SIZE, BY POWDERS, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL HERBAL MEDICINE MARKET SIZE, BY HERBAL BLEND POWDERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL HERBAL MEDICINE MARKET SIZE, BY HERBAL BLEND POWDERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL HERBAL MEDICINE MARKET SIZE, BY HERBAL BLEND POWDERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL HERBAL MEDICINE MARKET SIZE, BY SINGLE HERB POWDERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL HERBAL MEDICINE MARKET SIZE, BY SINGLE HERB POWDERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL HERBAL MEDICINE MARKET SIZE, BY SINGLE HERB POWDERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL HERBAL MEDICINE MARKET SIZE, BY SYRUPS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL HERBAL MEDICINE MARKET SIZE, BY SYRUPS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL HERBAL MEDICINE MARKET SIZE, BY SYRUPS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL HERBAL MEDICINE MARKET SIZE, BY SYRUPS, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL HERBAL MEDICINE MARKET SIZE, BY HONEY-BASED SYRUPS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL HERBAL MEDICINE MARKET SIZE, BY HONEY-BASED SYRUPS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL HERBAL MEDICINE MARKET SIZE, BY HONEY-BASED SYRUPS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL HERBAL MEDICINE MARKET SIZE, BY SUGAR-BASED SYRUPS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL HERBAL MEDICINE MARKET SIZE, BY SUGAR-BASED SYRUPS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL HERBAL MEDICINE MARKET SIZE, BY SUGAR-BASED SYRUPS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL HERBAL MEDICINE MARKET SIZE, BY TABLETS & CAPSULES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL HERBAL MEDICINE MARKET SIZE, BY TABLETS & CAPSULES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL HERBAL MEDICINE MARKET SIZE, BY TABLETS & CAPSULES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL HERBAL MEDICINE MARKET SIZE, BY TABLETS & CAPSULES, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL HERBAL MEDICINE MARKET SIZE, BY CHEWABLE TABLETS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL HERBAL MEDICINE MARKET SIZE, BY CHEWABLE TABLETS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL HERBAL MEDICINE MARKET SIZE, BY CHEWABLE TABLETS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL HERBAL MEDICINE MARKET SIZE, BY COMPRESSED TABLETS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL HERBAL MEDICINE MARKET SIZE, BY COMPRESSED TABLETS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL HERBAL MEDICINE MARKET SIZE, BY COMPRESSED TABLETS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL HERBAL MEDICINE MARKET SIZE, BY EFFERVESCENT TABLETS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL HERBAL MEDICINE MARKET SIZE, BY EFFERVESCENT TABLETS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL HERBAL MEDICINE MARKET SIZE, BY EFFERVESCENT TABLETS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL HERBAL MEDICINE MARKET SIZE, BY TRADITIONAL SYSTEM, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL HERBAL MEDICINE MARKET SIZE, BY AYURVEDA, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL HERBAL MEDICINE MARKET SIZE, BY AYURVEDA, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL HERBAL MEDICINE MARKET SIZE, BY AYURVEDA, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL HERBAL MEDICINE MARKET SIZE, BY TIBETAN & MONGOLIAN MEDICINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL HERBAL MEDICINE MARKET SIZE, BY TIBETAN & MONGOLIAN MEDICINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL HERBAL MEDICINE MARKET SIZE, BY TIBETAN & MONGOLIAN MEDICINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL HERBAL MEDICINE MARKET SIZE, BY TRADITIONAL CHINESE MEDICINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL HERBAL MEDICINE MARKET SIZE, BY TRADITIONAL CHINESE MEDICINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL HERBAL MEDICINE MARKET SIZE, BY TRADITIONAL CHINESE MEDICINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL HERBAL MEDICINE MARKET SIZE, BY TRADITIONAL JAPANESE MEDICINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL HERBAL MEDICINE MARKET SIZE, BY TRADITIONAL JAPANESE MEDICINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL HERBAL MEDICINE MARKET SIZE, BY TRADITIONAL JAPANESE MEDICINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL HERBAL MEDICINE MARKET SIZE, BY TRADITIONAL KOREAN MEDICINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL HERBAL MEDICINE MARKET SIZE, BY TRADITIONAL KOREAN MEDICINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL HERBAL MEDICINE MARKET SIZE, BY TRADITIONAL KOREAN MEDICINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL HERBAL MEDICINE MARKET SIZE, BY BOTANICAL ORIGIN, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL HERBAL MEDICINE MARKET SIZE, BY BARK, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL HERBAL MEDICINE MARKET SIZE, BY BARK, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL HERBAL MEDICINE MARKET SIZE, BY BARK, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL HERBAL MEDICINE MARKET SIZE, BY FLOWERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL HERBAL MEDICINE MARKET SIZE, BY FLOWERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL HERBAL MEDICINE MARKET SIZE, BY FLOWERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL HERBAL MEDICINE MARKET SIZE, BY FRUITS & SEEDS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL HERBAL MEDICINE MARKET SIZE, BY FRUITS & SEEDS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL HERBAL MEDICINE MARKET SIZE, BY FRUITS & SEEDS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL HERBAL MEDICINE MARKET SIZE, BY LEAVES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL HERBAL MEDICINE MARKET SIZE, BY LEAVES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL HERBAL MEDICINE MARKET SIZE, BY LEAVES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL HERBAL MEDICINE MARKET SIZE, BY ROOTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL HERBAL MEDICINE MARKET SIZE, BY ROOTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL HERBAL MEDICINE MARKET SIZE, BY ROOTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 111. GLOBAL HERBAL MEDICINE MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 112. GLOBAL HERBAL MEDICINE MARKET SIZE, BY CARDIOVASCULAR HEALTH, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 113. GLOBAL HERBAL MEDICINE MARKET SIZE, BY CARDIOVASCULAR HEALTH, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 114. GLOBAL HERBAL MEDICINE MARKET SIZE, BY CARDIOVASCULAR HEALTH, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 115. GLOBAL HERBAL MEDICINE MARKET SIZE, BY DIABETES MANAGEMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 116. GLOBAL HERBAL MEDICINE MARKET SIZE, BY DIABETES MANAGEMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 117. GLOBAL HERBAL MEDICINE MARKET SIZE, BY DIABETES MANAGEMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 118. GLOBAL HERBAL MEDICINE MARKET SIZE, BY DIGESTIVE DISORDERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 119. GLOBAL HERBAL MEDICINE MARKET SIZE, BY DIGESTIVE DISORDERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 120. GLOBAL HERBAL MEDICINE MARKET SIZE, BY DIGESTIVE DISORDERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 121. GLOBAL HERBAL MEDICINE MARKET SIZE, BY MENTAL HEALTH DISORDERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 122. GLOBAL HERBAL MEDICINE MARKET SIZE, BY MENTAL HEALTH DISORDERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 123. GLOBAL HERBAL MEDICINE MARKET SIZE, BY MENTAL HEALTH DISORDERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 124. GLOBAL HERBAL MEDICINE MARKET SIZE, BY PAIN MANAGEMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 125. GLOBAL HERBAL MEDICINE MARKET SIZE, BY PAIN MANAGEMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 126. GLOBAL HERBAL MEDICINE MARKET SIZE, BY PAIN MANAGEMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 127. GLOBAL HERBAL MEDICINE MARKET SIZE, BY RESPIRATORY DISORDERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 128. GLOBAL HERBAL MEDICINE MARKET SIZE, BY RESPIRATORY DISORDERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 129. GLOBAL HERBAL MEDICINE MARKET SIZE, BY RESPIRATORY DISORDERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 130. GLOBAL HERBAL MEDICINE MARKET SIZE, BY SKIN DISORDERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 131. GLOBAL HERBAL MEDICINE MARKET SIZE, BY SKIN DISORDERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 132. GLOBAL HERBAL MEDICINE MARKET SIZE, BY SKIN DISORDERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 133. GLOBAL HERBAL MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 134. GLOBAL HERBAL MEDICINE MARKET SIZE, BY OFFLINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 135. GLOBAL HERBAL MEDICINE MARKET SIZE, BY OFFLINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 136. GLOBAL HERBAL MEDICINE MARKET SIZE, BY OFFLINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 137. GLOBAL HERBAL MEDICINE MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
  • TABLE 138. GLOBAL HERBAL MEDICINE MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 139. GLOBAL HERBAL MEDICINE MARKET SIZE, BY DIRECT SALES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 140. GLOBAL HERBAL MEDICINE MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 141. GLOBAL HERBAL MEDICINE MARKET SIZE, BY PHARMACIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 142. GLOBAL HERBAL MEDICINE MARKET SIZE, BY PHARMACIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 143. GLOBAL HERBAL MEDICINE MARKET SIZE, BY PHARMACIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 144. GLOBAL HERBAL MEDICINE MARKET SIZE, BY SUPERMARKETS / HYPERMARKETS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 145. GLOBAL HERBAL MEDICINE MARKET SIZE, BY SUPERMARKETS / HYPERMARKETS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 146. GLOBAL HERBAL MEDICINE MARKET SIZE, BY SUPERMARKETS / HYPERMARKETS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 147. GLOBAL HERBAL MEDICINE MARKET SIZE, BY ONLINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 148. GLOBAL HERBAL MEDICINE MARKET SIZE, BY ONLINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 149. GLOBAL HERBAL MEDICINE MARKET SIZE, BY ONLINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 150. GLOBAL HERBAL MEDICINE MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 151. GLOBAL HERBAL MEDICINE MARKET SIZE, BY COMPANY WEBSITE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 152. GLOBAL HERBAL MEDICINE MARKET SIZE, BY COMPANY WEBSITE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 153. GLOBAL HERBAL MEDICINE MARKET SIZE, BY COMPANY WEBSITE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 154. GLOBAL HERBAL MEDICINE MARKET SIZE, BY ECOMMERCE WEBSITE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 155. GLOBAL HERBAL MEDICINE MARKET SIZE, BY ECOMMERCE WEBSITE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 156. GLOBAL HERBAL MEDICINE MARKET SIZE, BY ECOMMERCE WEBSITE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 157. GLOBAL HERBAL MEDICINE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 158. AMERICAS HERBAL MEDICINE MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 159. AMERICAS HERBAL MEDICINE MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 160. AMERICAS HERBAL MEDICINE MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 161. AMERICAS HERBAL MEDICINE MARKET SIZE, BY CREAMS & OINTMENTS, 2018-2032 (USD MILLION)
  • TABLE 162. AMERICAS HERBAL MEDICINE MARKET SIZE, BY LIQUID EXTRACTS, 2018-2032 (USD MILLION)
  • TABLE 163. AMERICAS HERBAL MEDICINE MARKET SIZE, BY OILS, 2018-2032 (USD MILLION)
  • TABLE 164. AMERICAS HERBAL MEDICINE MARKET SIZE, BY POWDERS, 2018-2032 (USD MILLION)
  • TABLE 165. AMERICAS HERBAL MEDICINE MARKET SIZE, BY SYRUPS, 2018-2032 (USD MILLION)
  • TABLE 166. AMERICAS HERBAL MEDICINE MARKET SIZE, BY TABLETS & CAPSULES, 2018-2032 (USD MILLION)
  • TABLE 167. AMERICAS HERBAL MEDICINE MARKET SIZE, BY TRADITIONAL SYSTEM, 2018-2032 (USD MILLION)
  • TABLE 168. AMERICAS HERBAL MEDICINE MARKET SIZE, BY BOTANICAL ORIGIN, 2018-2032 (USD MILLION)
  • TABLE 169. AMERICAS HERBAL MEDICINE MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 170. AMERICAS HERBAL MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 171. AMERICAS HERBAL MEDICINE MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
  • TABLE 172. AMERICAS HERBAL MEDICINE MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 173. NORTH AMERICA HERBAL MEDICINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 174. NORTH AMERICA HERBAL MEDICINE MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 175. NORTH AMERICA HERBAL MEDICINE MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 176. NORTH AMERICA HERBAL MEDICINE MARKET SIZE, BY CREAMS & OINTMENTS, 2018-2032 (USD MILLION)
  • TABLE 177. NORTH AMERICA HERBAL MEDICINE MARKET SIZE, BY LIQUID EXTRACTS, 2018-2032 (USD MILLION)
  • TABLE 178. NORTH AMERICA HERBAL MEDICINE MARKET SIZE, BY OILS, 2018-2032 (USD MILLION)
  • TABLE 179. NORTH AMERICA HERBAL MEDICINE MARKET SIZE, BY POWDERS, 2018-2032 (USD MILLION)
  • TABLE 180. NORTH AMERICA HERBAL MEDICINE MARKET SIZE, BY SYRUPS, 2018-2032 (USD MILLION)
  • TABLE 181. NORTH AMERICA HERBAL MEDICINE MARKET SIZE, BY TABLETS & CAPSULES, 2018-2032 (USD MILLION)
  • TABLE 182. NORTH AMERICA HERBAL MEDICINE MARKET SIZE, BY TRADITIONAL SYSTEM, 2018-2032 (USD MILLION)
  • TABLE 183. NORTH AMERICA HERBAL MEDICINE MARKET SIZE, BY BOTANICAL ORIGIN, 2018-2032 (USD MILLION)
  • TABLE 184. NORTH AMERICA HERBAL MEDICINE MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 185. NORTH AMERICA HERBAL MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 186. NORTH AMERICA HERBAL MEDICINE MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
  • TABLE 187. NORTH AMERICA HERBAL MEDICINE MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 188. LATIN AMERICA HERBAL MEDICINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 189. LATIN AMERICA HERBAL MEDICINE MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 190. LATIN AMERICA HERBAL MEDICINE MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 191. LATIN AMERICA HERBAL MEDICINE MARKET SIZE, BY CREAMS & OINTMENTS, 2018-2032 (USD MILLION)
  • TABLE 192. LATIN AMERICA HERBAL MEDICINE MARKET SIZE, BY LIQUID EXTRACTS, 2018-2032 (USD MILLION)
  • TABLE 193. LATIN AMERICA HERBAL MEDICINE MARKET SIZE, BY OILS, 2018-2032 (USD MILLION)
  • TABLE 194. LATIN AMERICA HERBAL MEDICINE MARKET SIZE, BY POWDERS, 2018-2032 (USD MILLION)
  • TABLE 195. LATIN AMERICA HERBAL MEDICINE MARKET SIZE, BY SYRUPS, 2018-2032 (USD MILLION)
  • TABLE 196. LATIN AMERICA HERBAL MEDICINE MARKET SIZE, BY TABLETS & CAPSULES, 2018-2032 (USD MILLION)
  • TABLE 197. LATIN AMERICA HERBAL MEDICINE MARKET SIZE, BY TRADITIONAL SYSTEM, 2018-2032 (USD MILLION)
  • TABLE 198. LATIN AMERICA HERBAL MEDICINE MARKET SIZE, BY BOTANICAL ORIGIN, 2018-2032 (USD MILLION)
  • TABLE 199. LATIN AMERICA HERBAL MEDICINE MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 200. LATIN AMERICA HERBAL MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 201. LATIN AMERICA HERBAL MEDICINE MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
  • TABLE 202. LATIN AMERICA HERBAL MEDICINE MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 203. EUROPE, MIDDLE EAST & AFRICA HERBAL MEDICINE MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 204. EUROPE, MIDDLE EAST & AFRICA HERBAL MEDICINE MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 205. EUROPE, MIDDLE EAST & AFRICA HERBAL MEDICINE MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 206. EUROPE, MIDDLE EAST & AFRICA HERBAL MEDICINE MARKET SIZE, BY CREAMS & OINTMENTS, 2018-2032 (USD MILLION)
  • TABLE 207. EUROPE, MIDDLE EAST & AFRICA HERBAL MEDICINE MARKET SIZE, BY LIQUID EXTRACTS, 2018-2032 (USD MILLION)
  • TABLE 208. EUROPE, MIDDLE EAST & AFRICA HERBAL MEDICINE MARKET SIZE, BY OILS, 2018-2032 (USD MILLION)
  • TABLE 209. EUROPE, MIDDLE EAST & AFRICA HERBAL MEDICINE MARKET SIZE, BY POWDERS, 2018-2032 (USD MILLION)
  • TABLE 210. EUROPE, MIDDLE EAST & AFRICA HERBAL MEDICINE MARKET SIZE, BY SYRUPS, 2018-2032 (USD MILLION)
  • TABLE 211. EUROPE, MIDDLE EAST & AFRICA HERBAL MEDICINE MARKET SIZE, BY TABLETS & CAPSULES, 2018-2032 (USD MILLION)
  • TABLE 212. EUROPE, MIDDLE EAST & AFRICA HERBAL MEDICINE MARKET SIZE, BY TRADITIONAL SYSTEM, 2018-2032 (USD MILLION)
  • TABLE 213. EUROPE, MIDDLE EAST & AFRICA HERBAL MEDICINE MARKET SIZE, BY BOTANICAL ORIGIN, 2018-2032 (USD MILLION)
  • TABLE 214. EUROPE, MIDDLE EAST & AFRICA HERBAL MEDICINE MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 215. EUROPE, MIDDLE EAST & AFRICA HERBAL MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 216. EUROPE, MIDDLE EAST & AFRICA HERBAL MEDICINE MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
  • TABLE 217. EUROPE, MIDDLE EAST & AFRICA HERBAL MEDICINE MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 218. EUROPE HERBAL MEDICINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 219. EUROPE HERBAL MEDICINE MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 220. EUROPE HERBAL MEDICINE MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 221. EUROPE HERBAL MEDICINE MARKET SIZE, BY CREAMS & OINTMENTS, 2018-2032 (USD MILLION)
  • TABLE 222. EUROPE HERBAL MEDICINE MARKET SIZE, BY LIQUID EXTRACTS, 2018-2032 (USD MILLION)
  • TABLE 223. EUROPE HERBAL MEDICINE MARKET SIZE, BY OILS, 2018-2032 (USD MILLION)
  • TABLE 224. EUROPE HERBAL MEDICINE MARKET SIZE, BY POWDERS, 2018-2032 (USD MILLION)
  • TABLE 225. EUROPE HERBAL MEDICINE MARKET SIZE, BY SYRUPS, 2018-2032 (USD MILLION)
  • TABLE 226. EUROPE HERBAL MEDICINE MARKET SIZE, BY TABLETS & CAPSULES, 2018-2032 (USD MILLION)
  • TABLE 227. EUROPE HERBAL MEDICINE MARKET SIZE, BY TRADITIONAL SYSTEM, 2018-2032 (USD MILLION)
  • TABLE 228. EUROPE HERBAL MEDICINE MARKET SIZE, BY BOTANICAL ORIGIN, 2018-2032 (USD MILLION)
  • TABLE 229. EUROPE HERBAL MEDICINE MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 230. EUROPE HERBAL MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 231. EUROPE HERBAL MEDICINE MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
  • TABLE 232. EUROPE HERBAL MEDICINE MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 233. MIDDLE EAST HERBAL MEDICINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 234. MIDDLE EAST HERBAL MEDICINE MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 235. MIDDLE EAST HERBAL MEDICINE MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 236. MIDDLE EAST HERBAL MEDICINE MARKET SIZE, BY CREAMS & OINTMENTS, 2018-2032 (USD MILLION)
  • TABLE 237. MIDDLE EAST HERBAL MEDICINE MARKET SIZE, BY LIQUID EXTRACTS, 2018-2032 (USD MILLION)
  • TABLE 238. MIDDLE EAST HERBAL MEDICINE MARKET SIZE, BY OILS, 2018-2032 (USD MILLION)
  • TABLE 239. MIDDLE EAST HERBAL MEDICINE MARKET SIZE, BY POWDERS, 2018-2032 (USD MILLION)
  • TABLE 240. MIDDLE EAST HERBAL MEDICINE MARKET SIZE, BY SYRUPS, 2018-2032 (USD MILLION)
  • TABLE 241. MIDDLE EAST HERBAL MEDICINE MARKET SIZE, BY TABLETS & CAPSULES, 2018-2032 (USD MILLION)
  • TABLE 242. MIDDLE EAST HERBAL MEDICINE MARKET SIZE, BY TRADITIONAL SYSTEM, 2018-2032 (USD MILLION)
  • TABLE 243. MIDDLE EAST HERBAL MEDICINE MARKET SIZE, BY BOTANICAL ORIGIN, 2018-2032 (USD MILLION)
  • TABLE 244. MIDDLE EAST HERBAL MEDICINE MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 245. MIDDLE EAST HERBAL MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 246. MIDDLE EAST HERBAL MEDICINE MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
  • TABLE 247. MIDDLE EAST HERBAL MEDICINE MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 248. AFRICA HERBAL MEDICINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 249. AFRICA HERBAL MEDICINE MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 250. AFRICA HERBAL MEDICINE MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 251. AFRICA HERBAL MEDICINE MARKET SIZE, BY CREAMS & OINTMENTS, 2018-2032 (USD MILLION)
  • TABLE 252. AFRICA HERBAL MEDICINE MARKET SIZE, BY LIQUID EXTRACTS, 2018-2032 (USD MILLION)
  • TABLE 253. AFRICA HERBAL MEDICINE MARKET SIZE, BY OILS, 2018-2032 (USD MILLION)
  • TABLE 254. AFRICA HERBAL MEDICINE MARKET SIZE, BY POWDERS, 2018-2032 (USD MILLION)
  • TABLE 255. AFRICA HERBAL MEDICINE MARKET SIZE, BY SYRUPS, 2018-2032 (USD MILLION)
  • TABLE 256. AFRICA HERBAL MEDICINE MARKET SIZE, BY TABLETS & CAPSULES, 2018-2032 (USD MILLION)
  • TABLE 257. AFRICA HERBAL MEDICINE MARKET SIZE, BY TRADITIONAL SYSTEM, 2018-2032 (USD MILLION)
  • TABLE 258. AFRICA HERBAL MEDICINE MARKET SIZE, BY BOTANICAL ORIGIN, 2018-2032 (USD MILLION)
  • TABLE 259. AFRICA HERBAL MEDICINE MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 260. AFRICA HERBAL MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 261. AFRICA HERBAL MEDICINE MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
  • TABLE 262. AFRICA HERBAL MEDICINE MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 263. ASIA-PACIFIC HERBAL MEDICINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 264. ASIA-PACIFIC HERBAL MEDICINE MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 265. ASIA-PACIFIC HERBAL MEDICINE MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 266. ASIA-PACIFIC HERBAL MEDICINE MARKET SIZE, BY CREAMS & OINTMENTS, 2018-2032 (USD MILLION)
  • TABLE 267. ASIA-PACIFIC HERBAL MEDICINE MARKET SIZE, BY LIQUID EXTRACTS, 2018-2032 (USD MILLION)
  • TABLE 268. ASIA-PACIFIC HERBAL MEDICINE MARKET SIZE, BY OILS, 2018-2032 (USD MILLION)
  • TABLE 269. ASIA-PACIFIC HERBAL MEDICINE MARKET SIZE, BY POWDERS, 2018-2032 (USD MILLION)
  • TABLE 270. ASIA-PACIFIC HERBAL MEDICINE MARKET SIZE, BY SYRUPS, 2018-2032 (USD MILLION)
  • TABLE 271. ASIA-PACIFIC HERBAL MEDICINE MARKET SIZE, BY TABLETS & CAPSULES, 2018-2032 (USD MILLION)
  • TABLE 272. ASIA-PACIFIC HERBAL MEDICINE MARKET SIZE, BY TRADITIONAL SYSTEM, 2018-2032 (USD MILLION)
  • TABLE 273. ASIA-PACIFIC HERBAL MEDICINE MARKET SIZE, BY BOTANICAL ORIGIN, 2018-2032 (USD MILLION)
  • TABLE 274. ASIA-PACIFIC HERBAL MEDICINE MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 275. ASIA-PACIFIC HERBAL MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 276. ASIA-PACIFIC HERBAL MEDICINE MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
  • TABLE 277. ASIA-PACIFIC HERBAL MEDICINE MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 278. GLOBAL HERBAL MEDICINE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 279. ASEAN HERBAL MEDICINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 280. ASEAN HERBAL MEDICINE MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 281. ASEAN HERBAL MEDICINE MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 282. ASEAN HERBAL MEDICINE MARKET SIZE, BY CREAMS & OINTMENTS, 2018-2032 (USD MILLION)
  • TABLE 283. ASEAN HERBAL MEDICINE MARKET SIZE, BY LIQUID EXTRACTS, 2018-2032 (USD MILLION)
  • TABLE 284. ASEAN HERBAL MEDICINE MARKET SIZE, BY OILS, 2018-2032 (USD MILLION)
  • TABLE 285. ASEAN HERBAL MEDICINE MARKET SIZE, BY POWDERS, 2018-2032 (USD MILLION)
  • TABLE 286. ASEAN HERBAL MEDICINE MARKET SIZE, BY SYRUPS, 2018-2032 (USD MILLION)
  • TABLE 287. ASEAN HERBAL MEDICINE MARKET SIZE, BY TABLETS & CAPSULES, 2018-2032 (USD MILLION)
  • TABLE 288. ASEAN HERBAL MEDICINE MARKET SIZE, BY TRADITIONAL SYSTEM, 2018-2032 (USD MILLION)
  • TABLE 289. ASEAN HERBAL MEDICINE MARKET SIZE, BY BOTANICAL ORIGIN, 2018-2032 (USD MILLION)
  • TABLE 290. ASEAN HERBAL MEDICINE MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 291. ASEAN HERBAL MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 292. ASEAN HERBAL MEDICINE MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
  • TABLE 293. ASEAN HERBAL MEDICINE MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 294. GCC HERBAL MEDICINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 295. GCC HERBAL MEDICINE MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 296. GCC HERBAL MEDICINE MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 297. GCC HERBAL MEDICINE MARKET SIZE, BY CREAMS & OINTMENTS, 2018-2032 (USD MILLION)
  • TABLE 298. GCC HERBAL MEDICINE MARKET SIZE, BY LIQUID EXTRACTS, 2018-2032 (USD MILLION)
  • TABLE 299. GCC HERBAL MEDICINE MARKET SIZE, BY OILS, 2018-2032 (USD MILLION)
  • TABLE 300. GCC HERBAL MEDICINE MARKET SIZE, BY POWDERS, 2018-2032 (USD MILLION)
  • TABLE 301. GCC HERBAL MEDICINE MARKET SIZE, BY SYRUPS, 2018-2032 (USD MILLION)
  • TABLE 302. GCC HERBAL MEDICINE MARKET SIZE, BY TABLETS & CAPSULES, 2018-2032 (USD MILLION)
  • TABLE 303. GCC HERBAL MEDICINE MARKET SIZE, BY TRADITIONAL SYSTEM, 2018-2032 (USD MILLION)
  • TABLE 304. GCC HERBAL MEDICINE MARKET SIZE, BY BOTANICAL ORIGIN, 2018-2032 (USD MILLION)
  • TABLE 305. GCC HERBAL MEDICINE MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 306. GCC HERBAL MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 307. GCC HERBAL MEDICINE MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
  • TABLE 308. GCC HERBAL MEDICINE MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 309. EUROPEAN UNION HERBAL MEDICINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 310. EUROPEAN UNION HERBAL MEDICINE MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 311. EUROPEAN UNION HERBAL MEDICINE MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 312. EUROPEAN UNION HERBAL MEDICINE MARKET SIZE, BY CREAMS & OINTMENTS, 2018-2032 (USD MILLION)
  • TABLE 313. EUROPEAN UNION HERBAL MEDICINE MARKET SIZE, BY LIQUID EXTRACTS, 2018-2032 (USD MILLION)
  • TABLE 314. EUROPEAN UNION HERBAL MEDICINE MARKET SIZE, BY OILS, 2018-2032 (USD MILLION)
  • TABLE 315. EUROPEAN UNION HERBAL MEDICINE MARKET SIZE, BY POWDERS, 2018-2032 (USD MILLION)
  • TABLE 316. EUROPEAN UNION HERBAL MEDICINE MARKET SIZE, BY SYRUPS, 2018-2032 (USD MILLION)
  • TABLE 317. EUROPEAN UNION HERBAL MEDICINE MARKET SIZE, BY TABLETS & CAPSULES, 2018-2032 (USD MILLION)
  • TABLE 318. EUROPEAN UNION HERBAL MEDICINE MARKET SIZE, BY TRADITIONAL SYSTEM, 2018-2032 (USD MILLION)
  • TABLE 319. EUROPEAN UNION HERBAL MEDICINE MARKET SIZE, BY BOTANICAL ORIGIN, 2018-2032 (USD MILLION)
  • TABLE 320. EUROPEAN UNION HERBAL MEDICINE MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 321. EUROPEAN UNION HERBAL MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 322. EUROPEAN UNION HERBAL MEDICINE MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
  • TABLE 323. EUROPEAN UNION HERBAL MEDICINE MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 324. BRICS HERBAL MEDICINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 325. BRICS HERBAL MEDICINE MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 326. BRICS HERBAL MEDICINE MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 327. BRICS HERBAL MEDICINE MARKET SIZE, BY CREAMS & OINTMENTS, 2018-2032 (USD MILLION)
  • TABLE 328. BRICS HERBAL MEDICINE MARKET SIZE, BY LIQUID EXTRACTS, 2018-2032 (USD MILLION)
  • TABLE 329. BRICS HERBAL MEDICINE MARKET SIZE, BY OILS, 2018-2032 (USD MILLION)
  • TABLE 330. BRICS HERBAL MEDICINE MARKET SIZE, BY POWDERS, 2018-2032 (USD MILLION)
  • TABLE 331. BRICS HERBAL MEDICINE MARKET SIZE, BY SYRUPS, 2018-2032 (USD MILLION)
  • TABLE 332. BRICS HERBAL MEDICINE MARKET SIZE, BY TABLETS & CAPSULES, 2018-2032 (USD MILLION)
  • TABLE 333. BRICS HERBAL MEDICINE MARKET SIZE, BY TRADITIONAL SYSTEM, 2018-2032 (USD MILLION)
  • TABLE 334. BRICS HERBAL MEDICINE MARKET SIZE, BY BOTANICAL ORIGIN, 2018-2032 (USD MILLION)
  • TABLE 335. BRICS HERBAL MEDICINE MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 336. BRICS HERBAL MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 337. BRICS HERBAL MEDICINE MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
  • TABLE 338. BRICS HERBAL MEDICINE MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 339. G7 HERBAL MEDICINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 340. G7 HERBAL MEDICINE MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 341. G7 HERBAL MEDICINE MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 342. G7 HERBAL MEDICINE MARKET SIZE,